June 19, 2017
Rare Eye Disease Can Be Treated Off-Label With Rheumatoid Arthritis MedAccording to UPI, scientists have discovered the rheumatoid arthritis medication adalimumab can also effectively treat uveitis, a rare eye disease. Adalimumab has long been used to treat rheumatic diseases, and is injected by patients every two weeks during treatment. During the study, 217 adults who had active noninfectious intermediate uveitis, posterior uveitis, or panuveitis were randomly administered adalimumab in a 1:1 ratio matched by a placebo. Uveitis is a category of inflammatory diseases that produces swelling and damage in eye tissues. If left untreated, it can slightly reduce vision or lead to severe vision loss. Study author Barisani Asenbauer said in a press release the breakthrough "will significantly improve the management of uveitis patients who have only partially responded to corticosteroids, need a corticosteroid sparing therapy or who are unsuitable for treatment with corticosteroids." The was conducted by an international research team led by the Medical University of Vienna. The findings were published in the New England Journal of Medicine.
This video was produced by YT Wochit News using http://wochit.com